Matthew Kircher, MD
Otolaryngology · Maywood, ILNPI 1013176684
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,494 of the $15,981 with a category attached, or 71.9%. Johnson & Johnson accounts for 73.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $13,796 and has fallen 94.0% since, to $824 in 2025. Among otolaryngology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $551.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$12K
- Medical Device Business Services, Inc.$2K
- Oticon Medical, LLC$1K
- Cochlear Americas$836
- Stryker$124
- Advanced Bionics, LLC$38
What the payments were for
- Consulting fees$11,49472%
- Travel & lodging$1,83511%
- Food & beverage$2,65317%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $11,706 |
| Medical Device Business Services, Inc. | 10 | $2,055 |
| Oticon Medical, LLC | 4 | $1,221 |
| Cochlear Americas | 9 | $836 |
| Stryker | 1 | $124 |
| Advanced Bionics, LLC | 1 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,981 in reported general payments places this provider in the 90th percentile of 390 otolaryngology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nortriptyline Hcl | 78 | $1,923 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 26 | $213 |
| Triamcinolone Acetonide | 20 | $128 |
| Prednisone | 12 | $40 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Maywood
- Kevin WelchMaywood$32K
- Andrea ZieglerMaywood$23K
- Samantha CerasielloMaywood$7K
- David ConleyChicago$630K
- Jayant PintoChicago$628K
- Robert KernChicago$610K
- Robert NaclerioBurr Ridge$229K
- Michael HutzOak Park$103K
- Charles WeingartenGlenview$96K
- Victoria LeeChicago$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.